3
Announcements
Trials
Browse
Landscape
Status
Completed
24
Recruiting
6
Unknown
5
Terminated
5
Active not recruiting
3
Suspended
2
Withdrawn
1
Enrolling by invitation
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Thoracic
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Neoplasms
33
Breast Neoplasms
33
Lung Neoplasms
17
Colorectal Neoplasms
15
Prostatic Neoplasms
13
Carcinoma, Non-Small-Cell Lung
13
Hematologic Neoplasms
12
Carcinoma, Hepatocellular
12
Stomach Neoplasms
11
Pancreatic Neoplasms
11
Diabetes Mellitus
9
Melanoma
7
Disease
7
Colonic Neoplasms
7
Pulmonary Disease, Chronic Obstructive
6
Cardiovascular Diseases
6
Barrett Esophagus
6
Urinary Bladder Neoplasms
5
Rectal Neoplasms
5
Liver Neoplasms
5
Leukemia, Myeloid, Acute
5
Fatigue
5
Uterine Cervical Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Pheochromocytoma
4
Myasthenia Gravis
4
Multiple Myeloma
4
Lymphoma, Non-Hodgkin
4
Lymphoma
4
Lymphatic Metastasis
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
Observational
×
Colitis, Ulcerative
×
Clear all
NCT06583395
2024-11-01
QUANTUM
VitaMed Research LLC
Enrolling by invitation
3,000 enrolled